Provided by Tiger Fintech (Singapore) Pte. Ltd.

AEON Biopharma

0.8200
+0.090212.36%
Post-market: 0.7703-0.0497-6.06%19:58 EDT
Volume:651.87K
Turnover:505.64K
Market Cap:9.27M
PE:0.01
High:0.8300
Open:0.7302
Low:0.7040
Close:0.7298
Loading ...

Company Profile

Company Name:
AEON Biopharma
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
5
Office Location:
5 Park Plaza,Suite 1750,Irvine,California,United States
Zip Code:
92614
Fax:
- -
Introduction:
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed a Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of both chronic and episodic migraine. AEON Biopharma, Inc. is based in Irvine, California.